Become a better informed and smarter investor.

Not yet a subscriber?
CATEGORIES:
BUSINESS
Whether it is Bitcoin, Dogecoin, or any of the literally hundreds of digital currencies and assets available today, there is one thing that is certain.
There has never been more hype about an investment class. Period.
Even the Dutch Tulip Bubble, one of the greatest price bubbles of all time, doesn’t seem to have equalled what is going on today.
But just what does this all mean for the future of investing and where does blockchain fit in.
Apart from leading the listed company DigitalX [ASX:DCC], Executive Director Leigh Travers would be one of the most experienced people in Australia when it comes to digital assets.
I caught up with him recently for a series of interviews on this fascinating topic.
In the previous two parts of this series, we looked at digital assets as an investment class and how blockchain fits into the digital asset world. To wrap things up, in this last episode we discuss DigitalX, one of the oldest companies [2014] on the Australian Stick Exchange to specialize in this area.
Whether it is Bitcoin, Dogecoin, or any of the literally hundreds of digital currencies and assets available today, there is one thing that is certain.
There has never been more hype about an investment class. Period.
Even the Dutch Tulip Bubble, one of the greatest price bubbles of all time, doesn’t seem to have equaled what is going on today.
But just what does this all mean for the future of investing and even at the most basic level, what are some of the options available and how do you invest in them.
Apart from leading the listed company DigitalX [ASX:DCC], Executive Director Leigh Travers would be one of the most experienced people in Australia when it comes to digital assets.
I caught up with him recently for a series of interviews on this fascinating topic.
Here is part two in which we explore Blockchain.
Whether it is Bitcoin, Dogecoin, or any of the literally hundreds of digital currencies and assets available today, there is one thing that is certain.
There has never been more hype about an investment class. Period.
Even the Dutch Tulip Bubble, one of the greatest price bubbles of all time, doesn’t seem to have equaled what is going on today.
But just what does this all mean for the future of investing and even at the most basic level, what are some of the options available and how do you invest in them.
Apart from leading the listed company DigitalX [ASX:DGX], CEO Leigh Travers would be one of the most experienced people in Australia when it comes to digital assets.
I caught up with him recently for a series of interviews on this fascinating topic.
Here is part on.
Conversation 182: Icetana trading at all-time lows yet this video anomoly detection company has come a long way since then.
You may be increasingly reading lines like “…if a business is not embracing AI then they are already a lost cause.”
Is this claim just another way to sell AI or does it hold value for investors and therefore an insight into the direction for portfolio construction?
You may be increasingly reading lines like “…if a business is not embracing AI then they are already a lost cause.”
Is this claim just another way to sell AI or does it hold value for investors and therefore an insight into the direction for portfolio construction?
With 13% YOY revenue growth [86% of which is recurring] and a group turnover of >$27 million, Straker Transcriptions is in an acquisition growth phase. CEO Grant Straker says the business is in the mood for acquisition-driven growth, with $7.3 million cash and $8.0 million of new loan facilities. Straker Translations has developed a hybrid translation platform that utilises a combination of AI, machine learning, and a crowd-sourced pool of freelance translators. The company’s cloud-based platform manages the end-to-end translation process, leveraging AI and machine learning to create a first draft translation and subsequently matching the customer’s content with one or more of the approximately 13,000 crowd-sourced human freelance translators for refinement.
HEALTH
Conversation 184: How Mach 7 Technologies [ASX:M7T] says it is riding a growing trend away from legacy systems in hospital data collection, storage and AI analysis.
Conversation 183: A look at the fundamentals of USCOM - [ASX:UCM] an Australian medical device company - to see if claims of it being grossly undervalued stack up.
Conversation 179: Medadvisor says business is well undervalued.
MedAdvisor is a world-class medication management platform that empowers users to more simply manage their medication and improve adherence. MedAdvisor’s highly automated and intuitive software system connects users to tools and education materials from their local/preferred pharmacy. In the US, MedAdvisor can reach 1 in 2 Americans for opt-out health programs via ~25,000 pharmacies. In Australia, MedAdvisor has connected over 1.8 million users through more than 60% of Australian pharmacies.
ENVIRONMENT
With no other competitors enjoying the global reach of Envirosuite [ASX:EVS], the race is now on for the Australian environmental intelligence company to grab as much market share as it can according to their CEO. “It’s a bit like a land grab and we need to get as much as we can across the six continent,” Peter White told me recently. Envirosuite uses a mixture of clever and cutting edge monitoring, combined with AI and big data to create environmental intelligence covering air, water, noise and vibration for operators in airports, cities, construction, mining, heavy industry, waste and water.
MANUFACTURING
Conversation 174: How can you have a faster better and cheaper product and not sell a s*@#t load of it? That was the question I asked Uzi Breier, CEO of Dotz Nano an Israeli based tech business back in July 2019. But today the anti-counterfeiting, authentication and tracing solutions business appears to have turned the commercial corner. They recently picked up a $13 million dollar, three-year deal that could, if all the planets align, be worth close to double that. Then there is the “instant COVID test” that is being clinically trialled at the moment.
CEO Rob Bloomfield told me that there may be an issue around the group’s visibility and profile with investors. He believes some big contract wins could help in this regard. However, he says a company shift to more innovative use of Machine Learning and AI, applied to AVA’s 2.5k installed existing systems, along with a shift to licensing and partnering deals with local suppliers, is showing the way forward for the group. He cites a recent tender contract win with the Indian Army, to protect their fiber optic critical communications network as an example.
He also believes this approach will result in more recurring revenue and an opportunity for AVA to generate SaaS-type offerings based on learnings from ML and AI system updates.